Skip to main content
Top
Published in:

01-11-2024 | Review

The influence of non-cancer-related risk factors on the development of cancer-related lymphedema: a rapid review

Authors: Nicole L. Stout, McKinzey Dierkes, Jill M. Oliveri, Stanley Rockson, Electra D. Paskett

Published in: Medical Oncology | Issue 11/2024

Login to get access

Abstract

Extensive research supports an evidence-base for cancer treatment-related risk factors, including extent of lymph node dissection and use of radiotherapy, as contributing to secondary lymphedema. Additionally, comorbidities, such as higher body mass index, and vascular-related conditions are identified to further augment risk. While social determinants of health (SDOH) and socioeconomic factors are widely regarded as influencing an individual’s healthcare outcomes, including cancer risk and survival, these factors have not been explored as risk factors for developing secondary lymphedema. A rapid literature review explored the current evidence for SDOH as risk factors for lymphedema. Studies that were published over the last 10 years and that specifically analyzed social factors as variables associated with lymphedema were included. Studies that only characterized the social determinants of the study population were not included. Forty-nine studies were identified through a rapid literature review, and 13 studies that expressly analyzed social determinants as risk factors for secondary lymphedema were reviewed and extracted. All studies were conducted in patients with breast cancer-related lymphedema. Social risk factors included race, educational level, insurance type, and income level. These are consistent with the socioeconomic inequalities related to cancer survival. SDOH may influence the risk of developing cancer treatment-related health conditions like secondary lymphedema. Research trials studying cancer treatment-related conditions should collect consistent and robust data across social, behavioral, environmental, and economic domains and should analyze these variables to understand their contribution to study endpoints. Risk prediction modeling could be a future pathway to better incorporate social determinants, along with medical and co-morbidity data, to holistically understand lymphedema risk.
Appendix
Available only for authorised users
Literature
1.
go back to reference Huang Z, Wu S. Acceptance of disability, coping style, perceived social support and quality of life among patients with chronic lymphedema: a cross-sectional study. Support Care Cancer. 2022;30(5):4099–108.CrossRefPubMed Huang Z, Wu S. Acceptance of disability, coping style, perceived social support and quality of life among patients with chronic lymphedema: a cross-sectional study. Support Care Cancer. 2022;30(5):4099–108.CrossRefPubMed
2.
go back to reference McDuff SG, Mina AI, Brunelle CL, et al. Timing of lymphedema after treatment for breast cancer: when are patients most at risk? Int J Radiat Oncol Biol Phys. 2019;103(1):62–70.CrossRefPubMed McDuff SG, Mina AI, Brunelle CL, et al. Timing of lymphedema after treatment for breast cancer: when are patients most at risk? Int J Radiat Oncol Biol Phys. 2019;103(1):62–70.CrossRefPubMed
15.
go back to reference Beesley VL, Rowlands IJ, Hayes SC, et al. Incidence, risk factors and estimates of a woman’s risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer. Gynecol Oncol. 2015;136(1):87–93.CrossRefPubMed Beesley VL, Rowlands IJ, Hayes SC, et al. Incidence, risk factors and estimates of a woman’s risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer. Gynecol Oncol. 2015;136(1):87–93.CrossRefPubMed
22.
go back to reference Rockson SG, Zhou X, Zhao L, et al. Exploring disease interrelationships in patients with lymphatic disorders: a single center retrospective experience. Clin Transl Med. 2022;12(4):e760.CrossRefPubMedCentralPubMed Rockson SG, Zhou X, Zhao L, et al. Exploring disease interrelationships in patients with lymphatic disorders: a single center retrospective experience. Clin Transl Med. 2022;12(4):e760.CrossRefPubMedCentralPubMed
28.
go back to reference Gupta E, Mitchell CH, Ngo-Huang A, Manne R, Stout NL. Addressing social determinants of health to reduce disparities among individuals with cancer: insights for rehabilitation professionals. Curr Oncol Rep. 2023;25(6):659–69.CrossRefPubMed Gupta E, Mitchell CH, Ngo-Huang A, Manne R, Stout NL. Addressing social determinants of health to reduce disparities among individuals with cancer: insights for rehabilitation professionals. Curr Oncol Rep. 2023;25(6):659–69.CrossRefPubMed
29.
go back to reference Badger TA, Segrin C, Crane TE, et al. Social determinants of health and symptom burden during cancer treatment. Nurs Res. 2023;72(2):103–13.CrossRefPubMed Badger TA, Segrin C, Crane TE, et al. Social determinants of health and symptom burden during cancer treatment. Nurs Res. 2023;72(2):103–13.CrossRefPubMed
31.
go back to reference Fettes L, Neo J, Ashford S, Higginson IJ, Maddocks M. Trajectories of disability in activities of daily living in advanced cancer or respiratory disease: a systematic review. Disabil Rehabil. 2022;44(10):1790–801.CrossRefPubMed Fettes L, Neo J, Ashford S, Higginson IJ, Maddocks M. Trajectories of disability in activities of daily living in advanced cancer or respiratory disease: a systematic review. Disabil Rehabil. 2022;44(10):1790–801.CrossRefPubMed
33.
49.
go back to reference Meeske KA, Sullivan-Halley J, Smith AW, et al. Risk factors for arm lymphedema following breast cancer diagnosis in black women and white women. Breast Cancer Res Treat. 2009;113:383–91.CrossRefPubMed Meeske KA, Sullivan-Halley J, Smith AW, et al. Risk factors for arm lymphedema following breast cancer diagnosis in black women and white women. Breast Cancer Res Treat. 2009;113:383–91.CrossRefPubMed
50.
go back to reference Ding JF. Prospective surveillance and risk reduction of cancer treatment-related lymphedema: systematic review and meta-analysis. Oncol Nurs Forum. 2020;47(5):E161–70.CrossRefPubMed Ding JF. Prospective surveillance and risk reduction of cancer treatment-related lymphedema: systematic review and meta-analysis. Oncol Nurs Forum. 2020;47(5):E161–70.CrossRefPubMed
51.
go back to reference Karaca-Mandic P, Solid CA, Armer JM, Skoracki R, Campione E, Rockson SG. Lymphedema self-care: economic cost savings and opportunities to improve adherence. Cost Eff Resour Alloc. 2023;21(1):47.CrossRefPubMedCentralPubMed Karaca-Mandic P, Solid CA, Armer JM, Skoracki R, Campione E, Rockson SG. Lymphedema self-care: economic cost savings and opportunities to improve adherence. Cost Eff Resour Alloc. 2023;21(1):47.CrossRefPubMedCentralPubMed
54.
go back to reference Papageorge MV, Woods AP, de Geus SW, et al. The persistence of poverty and its impact on cancer diagnosis, treatment and survival. Ann Surg. 2023;277(6):995–1001.CrossRefPubMed Papageorge MV, Woods AP, de Geus SW, et al. The persistence of poverty and its impact on cancer diagnosis, treatment and survival. Ann Surg. 2023;277(6):995–1001.CrossRefPubMed
55.
go back to reference Boscoe FP, Henry KA, Sherman RL, Johnson CJ. The relationship between cancer incidence, stage and poverty in the United States. Int J Cancer. 2016;139(3):607–12.CrossRefPubMed Boscoe FP, Henry KA, Sherman RL, Johnson CJ. The relationship between cancer incidence, stage and poverty in the United States. Int J Cancer. 2016;139(3):607–12.CrossRefPubMed
56.
go back to reference Bian J, Shen A, Yang W, Zhang L, Qiang W. Financial toxicity experienced by patients with breast cancer-related lymphedema: a systematic review. Support Care Cancer. 2023;31(6):354.CrossRefPubMed Bian J, Shen A, Yang W, Zhang L, Qiang W. Financial toxicity experienced by patients with breast cancer-related lymphedema: a systematic review. Support Care Cancer. 2023;31(6):354.CrossRefPubMed
57.
go back to reference Dean LT, Moss SL, Ransome Y, et al. “It still affects our economic situation”: long-term economic burden of breast cancer and lymphedema. Support Care Cancer. 2019;27:1697–708.CrossRefPubMed Dean LT, Moss SL, Ransome Y, et al. “It still affects our economic situation”: long-term economic burden of breast cancer and lymphedema. Support Care Cancer. 2019;27:1697–708.CrossRefPubMed
58.
go back to reference Boyages J, Xu Y, Kalfa S, et al. Financial cost of lymphedema borne by women with breast cancer. Psychooncology. 2017;26(6):849–55.CrossRefPubMed Boyages J, Xu Y, Kalfa S, et al. Financial cost of lymphedema borne by women with breast cancer. Psychooncology. 2017;26(6):849–55.CrossRefPubMed
62.
go back to reference Hong Y-R, Wang R, Case S, Jo A, Turner K, Ross KM. Association of food insecurity with overall and disease-specific mortality among cancer survivors in the US. Support Care Cancer. 2024;32(5):309.CrossRefPubMed Hong Y-R, Wang R, Case S, Jo A, Turner K, Ross KM. Association of food insecurity with overall and disease-specific mortality among cancer survivors in the US. Support Care Cancer. 2024;32(5):309.CrossRefPubMed
63.
go back to reference Parks CA, Carpenter LR, Sullivan KR, et al. A scoping review of food insecurity and related factors among cancer survivors. Nutrients. 2022;14(13):2723.CrossRefPubMedCentralPubMed Parks CA, Carpenter LR, Sullivan KR, et al. A scoping review of food insecurity and related factors among cancer survivors. Nutrients. 2022;14(13):2723.CrossRefPubMedCentralPubMed
65.
go back to reference Alcaraz KI, Wiedt TL, Daniels EC, Yabroff KR, Guerra CE, Wender RC. Understanding and addressing social determinants to advance cancer health equity in the United States: a blueprint for practice, research, and policy. CA Cancer J Clin. 2020;70(1):31–46.CrossRefPubMed Alcaraz KI, Wiedt TL, Daniels EC, Yabroff KR, Guerra CE, Wender RC. Understanding and addressing social determinants to advance cancer health equity in the United States: a blueprint for practice, research, and policy. CA Cancer J Clin. 2020;70(1):31–46.CrossRefPubMed
67.
go back to reference Lynch S, Street NW, Sharpe L, Kellish A. Social determinants of health screening: primary care PRAPARE tool implementation. J Nurse Pract. 2024;20(4):104955.CrossRef Lynch S, Street NW, Sharpe L, Kellish A. Social determinants of health screening: primary care PRAPARE tool implementation. J Nurse Pract. 2024;20(4):104955.CrossRef
68.
71.
go back to reference Obeng-Gyasi S, Elsaid MI, Lu Y, et al. Association of allostatic load with all-cause mortality in patients with breast cancer. JAMA Netw Open. 2023;6(5):e2313989.CrossRefPubMedCentralPubMed Obeng-Gyasi S, Elsaid MI, Lu Y, et al. Association of allostatic load with all-cause mortality in patients with breast cancer. JAMA Netw Open. 2023;6(5):e2313989.CrossRefPubMedCentralPubMed
72.
go back to reference Obeng-Gyasi S, Graham N, Kumar S, et al. Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patients. Blood Cancer J. 2022;12(4):53.CrossRefPubMedCentralPubMed Obeng-Gyasi S, Graham N, Kumar S, et al. Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patients. Blood Cancer J. 2022;12(4):53.CrossRefPubMedCentralPubMed
73.
go back to reference Chen J, Elsaid MI, Handley D, et al. Allostatic load as a predictor of postoperative complications in patients with breast cancer. NPJ Breast Cancer. 2024;10(1):44.CrossRefPubMedCentralPubMed Chen J, Elsaid MI, Handley D, et al. Allostatic load as a predictor of postoperative complications in patients with breast cancer. NPJ Breast Cancer. 2024;10(1):44.CrossRefPubMedCentralPubMed
Metadata
Title
The influence of non-cancer-related risk factors on the development of cancer-related lymphedema: a rapid review
Authors
Nicole L. Stout
McKinzey Dierkes
Jill M. Oliveri
Stanley Rockson
Electra D. Paskett
Publication date
01-11-2024
Publisher
Springer US
Published in
Medical Oncology / Issue 11/2024
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-024-02474-7

Other articles of this Issue 11/2024

Medical Oncology 11/2024 Go to the issue

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Live: Wednesday 29th January, 18:00-19:30 CET

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more